IC
CVS icon

Intersect Capital’s CVS Health CVS Stock Holding History

Intersect Capital’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$2.89M Sell
31,194
-4,508
-13% -$440K 0.87% 21
2022
Q1 		$3.61M Sell
35,702
-411
-1% -$43.2K 0.69% 22
2021
Q4 		$3.73M Sell
36,113
-11,400
-24% -$1.05M 0.69% 23
2021
Q3 		$4.03M Buy
47,513
+2,329
+5% +$195K 0.69% 25
2021
Q2 		$3.77M Buy
45,184
+238
+0.5% +$19.5K 0.67% 29
2021
Q1 		$3.38M Sell
44,946
-497
-1% -$36.2K 0.68% 29
2020
Q4 		$3.1M Buy
45,443
+2,069
+5% +$135K 0.68% 28
2020
Q3 		$2.53M Buy
43,374
+2,089
+5% +$130K 0.68% 29
2020
Q2 		$2.68M Buy
41,285
+6,488
+19% +$409K 0.86% 24
2020
Q1 		$2.06M Buy
34,797
+4,753
+16% +$317K 0.82% 26
2019
Q4 		$2.23M Buy
30,044
+2,102
+8% +$148K 0.75% 32
2019
Q3 		$1.76M Buy
27,942
+1,812
+7% +$107K 0.66% 31
2019
Q2 		$1.42M Buy
26,130
+8,398
+47% +$452K 0.55% 37
2019
Q1 		$956K Buy
17,732
+4,191
+31% +$259K 0.4% 52
2018
Q4 		$887K Buy
13,541
+1,919
+17% +$143K 0.43% 47
2018
Q3 		$915K Buy
11,622
+665
+6% +$47.5K 0.4% 52
2018
Q2 		$705K Buy
10,957
+440
+4% +$29K 0.34% 60
2018
Q1 		$654K Buy
10,517
+2,218
+27% +$159K 0.35% 59
2017
Q4 		$602K Buy
8,299
+419
+5% +$30.5K 0.32% 63
2017
Q3 		$641K Buy
7,880
+953
+14% +$75.4K 0.36% 59
2017
Q2 		$557K Buy
6,927
+1,764
+34% +$139K 0.33% 62
2017
Q1 		$405K Buy
5,163
+721
+16% +$57.6K 0.35% 58
2016
Q4 		$351K Buy
4,442
+1,439
+48% +$116K 0.26% 73
2016
Q3 		$267K Sell
3,003
-786
-21% -$74.2K 0.21% 80
2016
Q2 		$363K Hold
3,789
– – 0.22% 80
2016
Q1 		$393K Buy
3,789
+1,016
+37% +$98.8K 0.25% 76
2015
Q4 		$271K Sell
2,773
-20
-0.7% -$1.96K 0.23% 78
2015
Q3 		$269K Sell
2,793
-14
-0.5% -$1.47K 0.25% 76
2015
Q2 		$294K Hold
2,807
– – 0.25% 73
2015
Q1 		$279K Buy
+2,807
New +$284K 0.21% 70

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Intersect Capital's CVS Position: Q2 2022 in Review

Intersect Capital reduced its CVS Health (CVS) stake by 13% in Q2 2022, selling an estimated $440K and leaving 31,194 shares worth $2.89M. The position accounts for 0.87% of the portfolio, ranked #21.

Intersect Capital first reported a position in CVS in Q1 2015 and has held it in 30 quarters since. The position peaked at $4.03M in Q3 2021. 2,308 funds tracked by Wall St. Rank hold CVS as of Q2 2022.

  • Intersect Capital held 31,194 shares of CVS Health worth $2.89M as of Q2 2022.
  • Intersect Capital sold 4,508 CVS Health shares in Q2 2022, an estimated $440K.
  • CVS Health made up 0.87% of Intersect Capital's portfolio in Q2 2022, its #21 holding.
  • Intersect Capital first reported a position in CVS Health in Q1 2015 and has held it in 30 quarters since.
  • Intersect Capital's CVS Health position peaked at $4.03M in Q3 2021.
  • 2,308 funds tracked by Wall St. Rank held CVS Health as of Q2 2022.

Based on Intersect Capital's 13F filing for Q2 2022, filed 2 Sep 2022.